|
The New England Enzyme Center (NEEC) was created at the Tufts University School of Medicine in Boston, Massachusetts in 1964 as a federally supported biochemical resource center. ==History== According to Doogab Yi, by the late 1970s NEEC had been transformed into "several commercial biotech companies."〔 Roscoe O. Brady and his colleagues at National Institutes of Health (NIH) were almost ready for a clinical trial for a enzyme replacement therapy for Gaucher's disease that they had been working on for over a decade. They could not purify the enzyme in large enough quantities.〔 Blair had started his career in the biotechnology industry working as a technician at Tufts medical school.〔 In 1978 Henry E. Blair, from the NEEC and a team of researchers including Peter G. Pentchev, Roscoe O. Brady, Daniel E. Britton and Susan H. Sorrell from the National Institutes of Health co-authored a paper in the PNAS isolating and comparing enzymes in search of a treatment for Gaucher disease. In 1981 venture capitalist Sheridan Snyder, Henry Blair and George M. Whitesides created the start-up Genzyme and continued to produce the enzymes for the NIH. Genzyme's first office was an old clothing warehouse adjacent to Tufts Medical School.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「New England Enzyme Center」の詳細全文を読む スポンサード リンク
|